Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Zentalis Pharmaceuticals

    Client Virtual Booth

    ZENTALIS PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Zentalis Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    530 Seventh Avenue Suite 2201 New York, NY 10018
    Telephone
    Telephone
    1-212-433-3791
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://zentalis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zentalis-pharmaceuticals/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Zentalis to Highlight Preclinical Data Demonstrating Azenosertib at AACR
    Zentalis to Highlight Preclinical Data Demonstrating Azenosertib at AACR

    https://www.globenewswire.com/news-release/2024/04/02/2856461/0/en/Zentalis-Pharmaceuticals-to-Highlight-Preclinical-Data-Demonstrating-that-WEE1-Inhibitor-Azenosertib-Exerts-Synergistic-Anti-tumor-Activity-with-KRAS-G12C-Inhibitors-at-AACR-Annual.html

    GLOBENEWSWIRE
    02 Apr 2024
    Share Share
    Zentalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Zentalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/04/01/2855537/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Apr 2024
    Share Share
    Zentalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Zentalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/03/01/2839119/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Mar 2024
    Share Share
    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

    https://www.globenewswire.com//news-release/2024/02/28/2836781/0/en/Zentalis-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    28 Feb 2024
    Share Share
    Zentalis Reports Full Year 2023 Financial Results and Operational Updates
    Zentalis Reports Full Year 2023 Financial Results and Operational Updates

    https://www.globenewswire.com//news-release/2024/02/27/2835863/0/en/Zentalis-Pharmaceuticals-Reports-Full-Year-2023-Financial-Results-and-Operational-Updates.html

    GLOBENEWSWIRE
    27 Feb 2024
    Share Share
    Zentalis to Participate in the Oppenheimer Healthcare Life Sciences Conference
    Zentalis to Participate in the Oppenheimer Healthcare Life Sciences Conference

    https://www.globenewswire.com//news-release/2024/02/13/2828096/0/en/Zentalis-Pharmaceuticals-to-Participate-in-the-Oppenheimer-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    13 Feb 2024
    Share Share
    Zentalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Zentalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/02/01/2822501/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Feb 2024
    Share Share
    Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
    Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

    https://www.globenewswire.com//news-release/2024/01/25/2816572/0/en/Zentalis-Pharmaceuticals-Strengthens-Management-Team-with-Key-Appointments.html

    GLOBENEWSWIRE
    25 Jan 2024
    Share Share
    Immunome Licenses Zentalis ROR1 Antibody-Drug Conjugate
    Immunome Licenses Zentalis ROR1 Antibody-Drug Conjugate

    https://www.businesswire.com/news/home/20240108297637/en

    BUSINESSWIRE
    08 Jan 2024
    Share Share
    Zentalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Zentalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/01/02/2802959/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Jan 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search